Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial.
Impedance plethysmography is an accurate noninvasive method to test for proximal vein thrombosis, but it is insensitive to calf-vein thrombi. We randomly assigned patients on referral with clinically suspected deep-vein thrombosis and normal impedance plethysmographic findings to either serial impedance plethysmography alone or combined impedance plethysmography and leg scanning (which has been shown to be essentially as sensitive as venography) and compared the long-term outcomes. During the initial surveillance, deep-vein thrombosis was detected in 6 of 311 patients (1.9%) tested by serial impedance plethysmography alone and in 30 of 323 patients (9.3%) (most with calf-vein thrombi) tested by the combined approach (p less than 0.001). During long-term follow-up, no patient died from pulmonary embolism; but 6 patients (1.9%; 95% confidence limits, 0.7% to 4.2%) tested by serial impedance plethysmography developed deep-vein thrombosis compared with 7 patients (2.2%; 95% confidence limits, 0.9% to 4.4%) tested by the combined approach. Serial impedance plethysmography used alone is an effective strategy to evaluate such symptomatic patients.
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D005340:Fibrinogen; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D010992:Plethysmography, Impedance; D011655:Pulmonary Embolism / Q000209:etiology; D011877:Radionuclide Imaging; D011897:Random Allocation; D012107:Research Design; D013924:Thrombophlebitis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy
D000925:Anticoagulants; D007457:Iodine Radioisotopes; D005340:Fibrinogen